Mesenchymal Stem Cells for The Treatment of Frailty Syndrome

Clinical trial NCT04914403 · UNKNOWN

Trial details

NCT number: NCT04914403
Sponsor: Meridigen Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Frailty Syndrome

Start date: 2021-09-01
Primary completion: 2024-12-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.